Why You Should Use Kinetic Modelling For Every Late Phase Development Project
Date: 11 June 2020
Time: 15:00 (BST), 16.00 (CET), 10.00 (EDT), 7.00 (PDT)
Tutors: Dr Charles M Gordon
In the pharmaceutical industry the use of kinetic modelling has found patchy uptake. Modelling is often seen by chemists as ‘something that engineers do’, or misunderstood as ‘too much effort – I’d rather run more experiments’. However, well-directed kinetic modelling can be a game-changing activity in helping to accelerate chemical development, achieve right first time scale-up, successfully transfer technology and implement new manufacturing modalities.
This webinar will focus on the benefits offered by kinetic modelling, explaining how to:
• Gain value from kinetic modelling, especially minimising the amount of experiments and resources required for project delivery;
• Develop models that are ‘good enough’;
• Effectively combine kinetic modelling with Design of Experiments (DoE) studies;
• Use models as an aid to knowledge capture and tech transfer across teams and organisations;
• Use lab scale models during process scale-up and technology selection (e.g. flow processing).
The presenter, Dr Charlie Gordon, will draw on his personal experience of using kinetic modelling to support the development of API manufacturing processes at Pfizer, and more recently as a consultant working for Britest and Scale-up Systems, supporting process development for a wide range of organisations of different sizes. This webinar is kindly sponsored by Scale-up Systems and will take place at the following time:
15.00 BST (UK, Lisbon)
16.00 CET (Paris, Madrid, Frankfurt etc)
10.00 EDT (New York, Boston)
7.00 PDT (San Francisco, LA)
After registering, you will receive a confirmation email containing information about joining the webinar. We aim to record the session, all registrants will receive a link to the recording and copies of the slides at the end.